peptide hormone comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
The francium atoms leave the gold target as ions, which are neutralized by collision with yttrium and then isolated in a magneto-optical trap (MOT) in a gaseous unconsolidated state. Although the atoms only remain in the trap for about 30 seconds before escaping or undergoing nuclear decay, the process supplies a continual stream of fresh atoms. The result is a steady state containing a fairly constant number of atoms for a much longer time. The original apparatus could trap up to a few thousand atoms, while a later improved design could trap over 300,000 at a time. Sensitive measurements of the light emitted and absorbed by the trapped atoms provided the first experimental results on various transitions between atomic energy levels in francium. Initial measurements show very good agreement between experimental values and calculations based on quantum theory. The research project using this production method relocated to TRIUMF in 2012, where over 106 francium atoms have been held at a time, including large amounts of 209Fr in addition to 207Fr and 221Fr. Other synthesis methods include bombarding radium with neutrons, and bombarding thorium with protons, deuterons, or helium ions. 223Fr can also be isolated from samples of its parent 227Ac, the francium being milked via elution with NH4Cl–CrO3 from an actinium-containing cation exchanger and purified by passing the solution through a silicon dioxide compound loaded with barium sulfate.
== Clinical significance == Furin is one of the proteases responsible for the proteolytic cleavage of HIV envelope polyprotein precursor gp160 to gp120 and gp41 prior to viral assembly. This protease is also thought to play a role in tumor progression. The use of alternate polyadenylation sites has been found for the FURIN gene. Furin is enriched in the Golgi apparatus, where it functions to cleave other proteins into their mature/active forms. Furin cleaves proteins just downstream of a basic amino acid target sequence (canonically, Arg-X-(Arg/Lys) -Arg'). In addition to processing cellular precursor proteins, furin is also used by a number of pathogens. For example, the envelope proteins of viruses such as HIV, influenza, dengue fever, several filoviruses including ebola and marburg virus, and the spike protein of SARS-CoV-2, must be cleaved by furin or furin-like proteases to become fully functional. When SARS-CoV-2 virus is being synthesized in an infected cell, furin or furin-like proteases cleave the spike protein into two portions (S1 and S2), which remain associated. Anthrax toxin, Pseudomonas exotoxin, and papillomaviruses must be processed by furin during their initial entry into host cells. Inhibitors of furin are under consideration as therapeutic agents for treating anthrax infection. Furin is regulated by cholesterol and substrate presentation. When cholesterol is high, furin traffics to GM1 lipid rafts. When cholesterol is low, furin traffics to the disordered region. This is speculated to contribute to cholesterol and age dependent priming of SARS-CoV.
Administration: Administers the Secretariat as well as looks after personal matters of the Chairman/Members and other Officers/Staff of the commission. All India Services: Recruitment to All India Services is done either by direct recruitment, through Civil Services Examination or by promotion from the State Service. The AIS Branch handles the promotions of State Service officers to the IAS, IPS and IFS. It also handles policy matters relating to All India Services and amendments in the 'Promotion Regulations' of respective services. Appointments: It carries out appointments to central services based on Promotion (based on proposals from various Ministries/Departments/Union Territories and from certain local bodies) and by the means of Deputation and Absorption. Examinations: It carries out merit-based selection and recommendation of candidates through various examinations such as the Engineering Services Examination, Combined Medical Services Examination, Defence Services Examination, Civil Services Examination, etc., to Group A and Group B Services of the Government of India. General: Primarily deals with day-to-day housekeeping work for the Commission, such as arrangements and facilitation for the conduct of Examinations by the UPSC, printing the Annual Report, etc.
Sources: en.wikipedia.org
I have a fascination with how brainwashed people get with religion and how they'll give up their money, their time and their whole life for a cause that they're sure is right, but I'm sure is wrong. I think there's a lot of people who are scared of life and living and they want to make sure they get to Heaven or whatever. I try to stay away from it as much as I can. I was raised in the church until I was 16 and I've disagreed with their beliefs as long as I can remember, so when I had the choice I chose not to believe in anything apart from myself. Staley also stated in a 1999 interview that the song "Get Born Again" is about "religious hypocrisy". He approached music through his parents' collection, listening to Black Sabbath (regarded by him as his first influence) and Deep Purple. Other favorite bands include hard rock and metal bands like The Stooges, Anthrax, Judas Priest, Saxon, Rainbow, Mercyful Fate, Twisted Sister, Van Halen, and industrial/new wave acts such as Ministry, The Lords of the New Church and Skinny Puppy. He also cited Prince and David Bowie as two of his biggest idols. Staley began playing drums at age 12; he played in several glam bands in his early teens, but by this point, Staley had aspirations of becoming a singer. In 1984, Staley joined a group of Shorewood High students in a band called Sleze, which also featured future members of The Dehumanizers and Second Coming. In 1985, Staley and his band Sleze made a cameo in Father Rock, a low-budget movie from Seattle's Public Access Channel.
== Tourism == The World Economic Forum's Travel & Tourism Competitiveness Index 2017 Report, ranked Thailand 34 of 136 nations (1=most competitive, 136=least competitive). Other ASEAN nations ranked were: Singapore, 6; Malaysia, 26; Indonesia, 42; Vietnam, 67; Philippines, 79; Laos, 94; Cambodia, 101. International Tourist Arrivals and Receipts: Thailand ranked number nine in 2016, with 32.5 million arrivals. It ranked third in international tourism receipts, US$49.9 billion. Global Destinations Cities Index 2016: In this seventh annual survey published by MasterCard, Bangkok ranked number one of 100 cities worldwide as the top global destination city as determined by number of visitors. It displaced London, the previous number one. Other ASEAN cities ranked in the survey were Singapore, 6; Ho Chi Minh City, 42; Hanoi, 52; Jakarta, 66; and Manila, 74. Travel and Tourism Competitiveness Report 2015: Thailand ranked 35 of 141 nations. Among ASEAN nations, Singapore was ranked 11; Malaysia, 25: Indonesia, 50; Philippines, 74; Vietnam, 75; Laos, 96; Cambodia, 105; and Myanmar, 134. International Tourist Arrivals: Thailand ranked number ten in 2013, up five places from 2012 with 26.5 million arrivals. International Tourist Receipts: Ranked number seven in the world in 2013, up two places from 2012, with receipts estimated at US$42.1 billion. Total tourism contribution to GDP: Thailand ranked 18 of 184 nations in 2014, with travel and tourism income totalling 2,345 billion baht or 19.3 percent of GDP.
Harriet Jane Lawrence (September 13, 1883 – February 28, 1974) was an American physician and pathologist who was among the early women to specialize in laboratory medicine in the United States and the first known woman pathologist in Oregon. She earned her medical degree from Boston University School of Medicine in 1912 and established a clinical laboratory in Portland the following year, directing it for more than fifty years. During the 1918 influenza pandemic, Lawrence isolated hemolytic streptococcus from infected patients and developed a bacterial vaccine intended to combat secondary pneumonia associated with influenza. Although the viral cause of influenza was not yet understood, her work contributed to statewide treatment efforts and brought her national recognition. Over the course of her career, she supported the early medical career of Alan L. Hart and advocated for expanded opportunities for women in medicine.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.